Who
Ryan Cole
Chief Operating Officer
Company insider
Files Form 4 as: Chief Operating Officer, Aurinia Pharmaceuticals.
In numbers
- Trades disclosed
- 4
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 18 May 2026
- Last trade
- 18 May 2026
- Last filed
- 20 May 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 18 May 2026filed 20 May 2026 | AUPH Aurinia PharmaceuticalsBiotechnology | SEC FORM 4 Code A | —116,144 at $0.00 | filing |
| 18 May 2026filed 20 May 2026 | AUPH Aurinia Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —70,230 at $0.00 | filing |
| 18 May 2026filed 20 May 2026 | AUPH Aurinia Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —70,230 at $0.00 | filing |
| 18 May 2026filed 20 May 2026 | AUPH Aurinia PharmaceuticalsBiotechnology | SEC FORM 4 Code A | —116,144 at $0.00 | filing |
News
The case of Ryan Coles and UConn's failing conflict of interest policydailycampus.com · 25 Sep 2026
1 headline in the last 90 days name Ryan Cole; no company of theirs resolves to a name we track.
Sectors
No trade we could place in a sector.